BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Argentati C, Tortorella I, Bazzucchi M, Emiliani C, Morena F, Martino S. The Other Side of Alzheimer's Disease: Influence of Metabolic Disorder Features for Novel Diagnostic Biomarkers. J Pers Med 2020;10:E115. [PMID: 32899957 DOI: 10.3390/jpm10030115] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Villa C. Biomarkers for Alzheimer's Disease: Where Do We Stand and Where Are We Going? J Pers Med 2020;10:E238. [PMID: 33233492 DOI: 10.3390/jpm10040238] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Stanciu GD, Rusu RN, Bild V, Filipiuc LE, Tamba BI, Ababei DC. Systemic Actions of SGLT2 Inhibition on Chronic mTOR Activation as a Shared Pathogenic Mechanism between Alzheimer's Disease and Diabetes. Biomedicines 2021;9:576. [PMID: 34069618 DOI: 10.3390/biomedicines9050576] [Reference Citation Analysis]
3 Lynn J, Park M, Ogunwale C, Acquaah-Mensah GK. A Tale of Two Diseases: Exploring Mechanisms Linking Diabetes Mellitus with Alzheimer's Disease. J Alzheimers Dis 2021. [PMID: 34842187 DOI: 10.3233/JAD-210612] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]